维立志博-B涨超3% 5项血液肿瘤领域研究成果于2025 ASH年会公布
LEADS BIOLABS-BLEADS BIOLABS-B(HK:09887) Zhi Tong Cai Jing·2025-11-05 03:36

Core Viewpoint - The stock of Wuxi Biologics (09887) increased by over 3%, reaching HKD 57.9 with a trading volume of HKD 20.21 million, following the announcement of five research abstracts accepted for presentation at the 67th Annual Meeting of the American Society of Hematology (ASH) [1] Group 1 - On November 4, Wuxi Biologics announced that five research abstracts related to its innovative drugs LBL-034 and LBL-076 were accepted for the ASH annual meeting [1] - One clinical study of LBL-034 was selected for the first oral presentation on the first day of the conference, showcasing the latest efficacy and safety data for LBL-034 in patients with relapsed/refractory multiple myeloma [1]